January 04, 2017
Author: Marc Wortman
Opportunities to transform an industry are rare, but often they develop from unexpected sources. Long considered an essential yet largely commodity-output business, biopharmaceutical supply chain management may emerge as a hidden transformational force for the industry.
Pharmaceutical Commerce magazine Nov/Dec issue features an in-depth question and answer piece with Patheon CEO James Mullen. Patheon’s efforts and successes transforming contract manufacturing is profiled in the December issue of leading industry trade magazine, In Vivo.